| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms | Mediators of Inflammation | 2015 | 1,268 |
| 2 | The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis | Mediators of Inflammation | 2014 | 1,172 |
| 3 | Chronic Inflammation in Obesity and the Metabolic Syndrome | Mediators of Inflammation | 2010 | 859 |
| 4 | DAMPening Inflammation by Modulating TLR Signalling | Mediators of Inflammation | 2010 | 776 |
| 5 | κB Activations, Whereas Flavone, Isorhamnetin, Naringenin, and Pelargonidin Inhibit only NF-κB Activation along with Their Inhibitory Effect on iNOS Expression and NO Production in Activated Macrophages">Anti-Inflammatory Effects of Flavonoids: Genistein, Kaempferol, Quercetin, and Daidzein Inhibit STAT-1 and NF-κB Activations, Whereas Flavone, Isorhamnetin, Naringenin, and Pelargonidin Inhibit only NF-κB Activation along with Their Inhibitory Effect on iNOS Expression and NO Production in Activated Macrophages | Mediators of Inflammation | 2007 | 729 |
| 6 | α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in Patients With Active Psoriasis and Correlation With Disease Severity">Serum Levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in Patients With Active Psoriasis and Correlation With Disease Severity | Mediators of Inflammation | 2005 | 705 |
| 7 | Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment | Mediators of Inflammation | 2016 | 586 |
| 8 | LOX-1, OxLDL, and Atherosclerosis | Mediators of Inflammation | 2013 | 571 |
| 9 | Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View | Mediators of Inflammation | 2013 | 546 |
| 10 | Tumor Necrosis Factor Alpha: A Link between Neuroinflammation and Excitotoxicity | Mediators of Inflammation | 2014 | 536 |
| 11 | Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut | Mediators of Inflammation | 2015 | 487 |
| 12 | Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic Pain | Mediators of Inflammation | 2013 | 480 |
| 13 | Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis | Mediators of Inflammation | 2010 | 405 |
| 14 | Mediators of Inflammation in Acute Kidney Injury | Mediators of Inflammation | 2009 | 397 |
| 15 | The Role of Adipose Tissue and Adipokines in Obesity-Related Inflammatory Diseases | Mediators of Inflammation | 2010 | 397 |
| 16 | Exercise as a Mean to Control Low-Grade Systemic Inflammation | Mediators of Inflammation | 2008 | 383 |
| 17 | Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer’s Disease | Mediators of Inflammation | 2015 | 376 |
| 18 | The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases | Mediators of Inflammation | 2017 | 365 |
| 19 | The Inflammatory Chemokine CCL5 and Cancer Progression | Mediators of Inflammation | 2014 | 357 |
| 20 | Matrix Metalloproteinases: Inflammatory Regulators of Cell Behaviors in Vascular Formation and Remodeling | Mediators of Inflammation | 2013 | 351 |
| 21 | Inflammation in Diabetic Nephropathy | Mediators of Inflammation | 2012 | 345 |
| 22 | Role of Leptin in the Activation of Immune Cells | Mediators of Inflammation | 2010 | 328 |
| 23 | Angiogenesis and Its Therapeutic Opportunities | Mediators of Inflammation | 2013 | 325 |
| 24 | Dental Pulp Defence and Repair Mechanisms in Dental Caries | Mediators of Inflammation | 2015 | 322 |
| 25 | Thyroid Hormones, Oxidative Stress, and Inflammation | Mediators of Inflammation | 2016 | 320 |
| 26 | The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation | Mediators of Inflammation | 2016 | 317 |
| 27 | Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions | Mediators of Inflammation | 2019 | 312 |
| 28 | Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control | Mediators of Inflammation | 2016 | 303 |
| 29 | Inflammation, a Link between Obesity and Cardiovascular Disease | Mediators of Inflammation | 2010 | 302 |
| 30 | The Role of Inflammation in the Pathogenesis of Osteoarthritis | Mediators of Inflammation | 2020 | 299 |
| 31 | Ischemia/Reperfusion Injury following Acute Myocardial Infarction: A Critical Issue for Clinicians and Forensic Pathologists | Mediators of Inflammation | 2017 | 294 |
| 32 | The Role of Macrophages in the Pathogenesis of ALI/ARDS | Mediators of Inflammation | 2018 | 289 |
| 33 | Evidence for local inflammation in complex regional pain syndrome type 1 | Mediators of Inflammation | 2002 | 287 |
| 34 | Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus | Mediators of Inflammation | 2010 | 282 |
| 35 | Cytokine Levels in the Serum of Healthy Subjects | Mediators of Inflammation | 2013 | 281 |
| 36 | Functional Roles of p38 Mitogen-Activated Protein Kinase in Macrophage-Mediated Inflammatory Responses | Mediators of Inflammation | 2014 | 281 |
| 37 | Systemic Immune Activation Leads to Neuroinflammation and Sickness Behavior in Mice | Mediators of Inflammation | 2013 | 275 |
| 38 | Anti-inflammatory actions of acupuncture | Mediators of Inflammation | 2003 | 273 |
| 39 | Apocynin: Molecular Aptitudes | Mediators of Inflammation | 2008 | 273 |
| 40 | Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases | Mediators of Inflammation | 2013 | 263 |
| 41 | Antiinflammatory and Immunomodulating Properties of Fungal Metabolites | Mediators of Inflammation | 2005 | 257 |
| 42 | Myeloperoxidase: A New Biomarker of Inflammation in Ischemic Heart Disease and Acute Coronary Syndromes | Mediators of Inflammation | 2008 | 256 |
| 43 | The Th1:Th2 Dichotomy of Pregnancy and Preterm Labour | Mediators of Inflammation | 2012 | 250 |
| 44 | Macrophage Plasticity and the Role of Inflammation in Skeletal Muscle Repair | Mediators of Inflammation | 2013 | 250 |
| 45 | TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation | Mediators of Inflammation | 2016 | 248 |
| 46 | HIF1α-Induced Glycolysis Metabolism Is Essential to the Activation of Inflammatory Macrophages | Mediators of Inflammation | 2017 | 246 |
| 47 | Macrophages as Key Drivers of Cancer Progression and Metastasis | Mediators of Inflammation | 2017 | 245 |
| 48 | Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes | Mediators of Inflammation | 2014 | 242 |
| 49 | COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation | Mediators of Inflammation | 2021 | 241 |
| 50 | The Role of Src Kinase in Macrophage-Mediated Inflammatory Responses | Mediators of Inflammation | 2012 | 236 |
